drugset / Trial / NCT02119884

Hemodynamic Effects of Terlipressin and High Dose Octreotide

NCT02119884

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of the study is to find patients's response to terlipressin and octreotide during hepatic venous pressure gradient measurement by observing portal and systemic hemodynamics.

Timeline

Start
2014-02
Primary completion
2016-06
Completion
2016-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Octreotide Peptide 50 ug Intravenous
Subject Terlipressin Peptide 2 mg Intravenous

Indications